Royality Med's mission is to fast-track the early stage of drug discovery using our predictive models of the human brain for therapeutic success. Many neurodevelopmental diseases do not have treatments due to a lack of a-priori knowledge of the underlying biology. Royality Med's technology is able to model these diseases to help enable the discovery of new targets and drugs, de-risking the current failure-prone cumbersome approach.
For inquiries, please contact us at
E-mail: info@royalitymed.com
Contact Us
USA HEADQUARTERS
151 W 42nd St, New York, NY 10036, United States
info@royalitymed.com
+ 1 646-814-7022
UK HEADQUARTERS
51-34 Nottingham Pl, London W1U 5NY, United Kingdom
support@royalitymed.com
+ 44 7392 480154
I would like to learn about Royality Med’s Pharmaceuticals discoveries to treat genetic diseases.